Drug intelligence / Profile preview

alox15 siRNA

Development stage
Preclinical
Lead developer
Yale University
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Inhalation
01

Overview

alox15 siRNA is a small interfering RNA (siRNA) designed to silence the expression of the ALOX15 gene, which encodes the enzyme 15-lipoxygenase. In the context of respiratory research, particularly Type 2-high asthma, ALOX15 is a key mediator of airway inflammation induced by cytokines like IL-4 and IL-13. By targeting ALOX15 mRNA for degradation, this siRNA reduces the production of 15-lipoxygenase, thereby modulating downstream pathways such as ferroptosis, interleukin signaling, and macrophage activation. While currently utilized as a research tool in in vitro models (e.g., BEAS-2b cells), it represents a potential therapeutic strategy for managing eosinophilic airway inflammation and lung function impairment in asthma patients.

Other names
ALOX15 small interfering RNAALOX-15 small interfering RNAALOX 15 small interfering RNA15-lipoxygenase siRNA
02

Targets

Arachidonate 15-lipoxygenase (ALOX15) mRNAInnate immune RNA sensors

Beyond the preview

Go deeper on alox15 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alox15 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call